Targeted nanoparticles show success in clinical trials
Tiny particles designed to home in on cancer cells achieve tumor shrinkage at lower doses than traditional chemotherapy.
Tiny particles designed to home in on cancer cells achieve tumor shrinkage at lower doses than traditional chemotherapy.
Clinical trial of the programmable, implantable device shows promise in treating osteoporosis.
New MIT technology could lead to better drug delivery and artificial tissues that imitate natural tissue.